Abstract:
Dementia profoundly affects quality of life of patients as well as family and caregivers. Quality of life (QOL) refers to people’s emotional, social and physical wellbeing, and their ability to function in daily life. QOL measures attempt to evaluate directly the impact of dementia or interventions on people’s ability to function in life. Besides this global conceptualization of QOL there is a growing field of research on QOL measures focused on the measurement of health related quality of life (HRQL), i.e., a person’s satisfaction or happiness with domains of life insofar as they affect or are affected by the dementia. HRQL can be distinguished from QOL in that it concerns itself primarily with those factors that fall under the purview of health care providers and health care systems (QOL/HRQL). QOL measurement provides a subjective evaluation that captures benefits and harms of interventions not detected by standard clinical outcomes. Three methods of QOL assessment are available: self-report, proxy-report and proxy rating by direct observation of behavior assumed to be related to QOL. Acknowledging the problem of potential bias of proxy-reports, self-report methods are preferable if possible. If not, observational methods by an uninvolved professional are an acceptable alternative.
By content, QOL measurement scales also can be categorized into three groups: generic, domain-specific or disease-specific. Generic scales can be divided in health profiles and utility measurements. Health profiles classify subjects with respect to a broad spectrum of QOL domains, thus producing a descriptive profile from several health domains. Generic utility measures enable cost-utility analysis. Cost is measured in monetary units. Benefit is usually expressed in quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs). Domain-specific questionnaires rate QOL on circumscript areas, such as mobility, physical restrictions, autonomy or mastery. Dementia-specific measures probably have a higher grade of responsiveness, i.e., a higher ability to identify changes that relate to the natural course of dementia or treatment interventions.
QOL measurement methods in dementia are still facing important challenges. Measurement properties encompass reliability, validity and responsiveness. Responsiveness, the ability to detect relevant change over time in health status, is an essential property of outcome measures for intervention studies and still largely unclear in dementia research. Another important item is response shift, referring to the psychological adaptation of perception of QOL following a change in health status (e.g., progress of the dementia), which should also be addressed adequately. Next to the differential effects of dementia on the patients themselves, caring for people with dementia is often associated with increase in distress and decrease in mental health and wellbeing, thus affecting QOL of proxies as well. Therefore, despite the remaining scientific challenges in the field, it is highly recommendable to include QOL assessment of patients and proxies as endpoints in all dementia and MCI intervention trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AAI:
-
Activity and Affect Indicators of quality of life
- AD:
-
Alzheimer’s disease
- ADR-QL:
-
Alzheimer’s Disease health-Related Quality of Life scale
- BASQID:
-
Bath Assessment of Subjective Quality of Life in Dementia
- CBS:
-
Cornell-Brown Scale for quality of life in dementia
- CEA:
-
cost-effectiveness analysis
- CUA:
-
cost-utility analysis
- DALY:
-
disability-adjusted life years
- DCM:
-
Dementia Care Mapping
- DHP:
-
Duke Health Profile
- DQOL:
-
Dementia Quality of Life scale
- DSDAT:
-
Discomfort Scale-Dementia of Alzheimer Type
- EQ-5D:
-
European Quality of life - 5 Dimensions
- EQ-6D:
-
European Quality of life - 6 Dimensions
- HRQL:
-
health related quality of life
- HSQ:
-
Health Status Questionnaire
- HUI:
-
Health Utilities Index
- MCI:
-
Mild Cognitive Impairment
- MID:
-
minimal important difference
- NHP:
-
Nottingham Health Profile
- PDS:
-
Progressive Deterioration Scale
- PRO:
-
patient reported outcome
- PTO:
-
person trade-off
- PWB-CIP:
-
Psychological Well-Being in Cognitively Impaired Persons
- QALY:
-
quality-adjusted life year
- QOL:
-
quality of life
- QOL-AD:
-
Quality of Life-Alzheimer’s Disease scale
- QOL AS:
-
Quality of Life Assessment Schedule
- QOL-D:
-
Quality of Life for Dementia
- QUALID:
-
Quality of Life in Late-Stage Dementia scale
- QWB:
-
Quality of Well-Being scale
- RI:
-
responsiveness index
- SEM:
-
structural equation modeling
- SEIQOL:
-
Schedule for the Evaluation of Individual Quality of Life
- SF-6D:
-
SF-36 revised into a six-dimensional health state classification: SF-36, Medical Outcomes Study 36-item Short Form Health Survey
- SF-12:
-
Medical Outcomes Study 12-Item Short Form Health Survey
- SG:
-
standard gamble
- SIP:
-
Sickness Impact Profile
- TTO:
-
time trade-off
- VAS:
-
visual analogue scale
- WHOQOL 100:
-
World Health Organization Quality of Life 100
References
Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. (1996). J Am Geriatr Soc. 44: 1342–1347.
Albrecht GL, Devlieger PJ. (1999). Soc Sci Med. 48: 977–988.
Anderson RT, Aaronson NK, Bullinger M, McBee WL. (1996). Pharmacoeconomics. 10: 336–355.
Andresen EM, Rothenberg BM, Kaplan RM. (1998). Med Care. 36: 1349–1360.
Ankri J, Beaufils B, Novella JL, Morrone I, Guillemin F, Jolly D, Ploton L, Blanchard F. (2003). J Clin Epidemiol. 56: 1055–1063.
Bergner M, Bobbitt RA, Carter WB, Gilson BS. (1981). Med Care. 19: 787–805.
Birks J. (2006). Cochrane Database Syst Rev. CD005593.
Boyer F, Novella JL, Morrone I, Jolly D, Blanchard F. (2004). Int J Geriatr Psychiatry. 19: 1026–1034.
Brazier J, Deverill M, Green C, Harper R, Booth A. (1999). Health Technol. Assess. 3: i–164.
Brazier J, Roberts J, Deverill M. (2002). J Health Econ. 21: 271–292.
Brazier J, Roberts J, Tsuchiya A, Busschbach J. (2004). Health Econ. 13: 873–884.
Brod M, Stewart AL, Sands L. (1999). J Ment Health Aging. 5: 7–20.
Brooks R. (1996). EuroQol: the current state of play. Health Policy. 37: 53–72.
Bureau-Chalot F, Novella JL, Jolly D, Ankri J, Guillemin F, Blanchard F. (2002). Gerontology. 48: 220–225.
Burgener S, Twigg P. (2002). Alzheimer Dis Assoc Disord. 16: 88–102.
Coen R, O’Mahony D, O’Boyle C, et al. (1993). Ir J Psychology. 14: 154–163.
Conner-Spady B, Suarez-Almazor ME. (2003). Med Care. 41: 791–801.
Councill W, Bryan S, Bentham P, Buckley A, Laight A. (2001). Med Care. 39: 760–771.
De Jong R, Osterlund OW, Roy GW. (1989). Clin Ther. 11: 545–554.
Ettema TP, Droes RM, de Lange J, Mellenbergh GJ, Ribbe MW. (2005). Qual Life Res. 14: 675–686.
Ettema TP, Dröes RM, de Lange J, Mellenbergh GJ, Ribbe MW. (2007). Int J Geriatr Psychiatry. 22: 424–430.
Feeny D, Furlong W, Boyle M, Torrance GW. (1995). Pharmacoeconomics. 7: 490–502.
Furlong WJ, Feeny DH, Torrance GW, Barr RD. (2001). Ann Med. 33: 375–384.
Gonzalez-Salvador MT, Arango C, Lyketsos CG, Barba AC. (1999). Int J Geriatr Psychiatry. 14: 701–710.
Green C. (2001). Health Econ. 10: 233–243.
Guyatt G, Walter S, Norman G. (1987). J Chronic Dis. 40: 171–178.
Guyatt GH, Feeny DH, Patrick DL. (1993). Ann Intern Med. 118: 622–629.
Guyatt GH, Kirshner B, Jaeschke R. (1992). J Clin Epidemiol. 45: 1341–1345.
Hurley AC, Volicer BJ, Hanrahan PA, Houde S, Volicer L. (1992). Res Nurs Health. 15: 369–377.
Jonsson L, Andreasen N, Kilander L, Soininen H, Waldemar G, Nygaard H, Winblad B, Jonhagen ME, Hallikainen M, Wimo A. (2006). Alzheimer Dis Assoc Disord. 20: 49–55.
Joyce CR. (1994). J Cardiovasc Pharmacol 23 Suppl. 3: S26–S33.
Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E. (2007). Int Psychogeriatr. 19: 345–354.
Kerner DN, Patterson TL, Grant I, Kaplan RM. (1998). J Aging Health. 10: 44–61.
Kind P. (2003). In: Brooks R, Rabin R, Fd. Charro (ed.) The measurement and evaluation of health status using EQ-5D: A European perspective. Kluwer Academic Publishers.
Kitwood T, Bredin K. (1992). J Adv Health Nurs Care. 1: 41–60.
Korfage IJ, de Koning HJ, Essink-Bot ML. (2007). Qual Life Res. 16: 1627–1634.
Krabbe PF, Stouthard ME, Essink-Bot ML, Bonsel GJ. (1999). J Clin Epidemiol. 52: 293–301.
Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L. (2006). Health Econ. 15: 1229–1236.
Logsdon RG, Gibbons LE, McCurry SM, Teri L. (2002). Psychosom. Med. 64: 510–519.
Mack JL, Whitehouse PJ. (2001). Alzheimer Dis Assoc Disord. 15: 69–71.
Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile IM, Clarke AE, Gignac MA, Anis AH. (2007). J Clin Epidemiol. 60: 616–624.
McDonough CM, Tosteson AN. (2007). Pharmacoeconomics. 25: 93–106.
McGee HM, O’Boyle CA, Hickey A, O’Malley K, Joyce CR. (1991). Psychol Med. 21: 749–759.
Miguel RS, Lopez-Gonzalez AM, Sanchez-Iriso E, Mar J, Cabases JM. (2007). Pharm World Sci. 30: 154–160.
Missotten P, Ylieff M, Di Notte D, Paquay L, De Lepeleire J, Buntinx F, Fontaine O. (2007). Int J Geriatr Psychiatry. 22: 1201–1207.
Naglie G. (2007). Can J Neurol Sci 34 Suppl. 1: S57–S61.
Naglie G, Tomlinson G, Tansey C, Irvine J, Ritvo P, Black SE, Freedman M, Silberfeld M, Krahn M. (2006). Qual Life Res. 15: 631–643.
Neumann PJ, Kuntz KM, Leon J, Araki SS, Hermann RC, Hsu MA, Weinstein MC. (1999). Med Care. 37: 27–32.
Novella J, Ankri J, Morrone I, Guillemin F, Jolly D, Jochum C, Ploton L, Blanchard F. (2001). Dement Geriatr Cogn Disord. 12: 158–166.
Nowels D, McGloin J, Westfall JM, Holcomb S. (2005). Qual Life Res. 14: 95–105.
O’Boyle CA, McGee H, Hickey A, O’Malley K, Joyce CR. (1992). Lancet. 339: 1088–1091.
Pettit T, Livingston G, Manela M, Kitchen G, Katona C, Bowling A. (2001). Int J Geriatr Psychiatry. 16: 1061–1070.
Pinto Prades JL. (1997). Health Econ. 6: 71–81.
Porzsolt F, Kojer M, Schmidl M et al. (2004). Health Qual Life Outcomes. 2: 10–18.
Rabins PV. (2000). Int Psychogeriatr. 12: 47–49.
Rabins PV, Kasper JD, Kleinman L et al. (1999). J Ment Health Aging. 5: 33–48.
Räsänen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynanen OP, Roine R. (2006). Int J Technol Assess Health Care. 22: 235–241.
Ready RE, Ott BR, Grace J et al. (2002). Alzheimer Dis Assoc Disord. 16: 109–115.
Revicki D, Hays RD, Cella D, Sloan J. (2008). J Clin Epidemiol. 61: 102–109.
Sands LP, Ferreira P, Stewart AL, Brod M, Yaffe K. (2004). Am. J Geriatr Psychiatry. 12: 272–280.
Santaguida PS, Raina P, Booker L, Patterson C, Baldassarre F, Cowan D, Gauld M, Levine M, Unsal A. (2004). Evid.Rep.Technol.Assess (Summ.) 1–16.
Schölzel-Dorenbos CJ, Ettema TP, Bos J, Boelens-van der Knoop E, Gerritsen DL, Hoogeveen F, de Lange J, Meihuizen L, Droes RM. (2007a). Int J Geriatr Psychiatry. 22: 511–519.
Schölzel-Dorenbos CJ, van der Steen MJ, Engels LK, Olde Rikkert MG. (2007b). Alzheimer Dis Assoc Disord. 21: 172–178.
Schölzel-Dorenbos CJM. (2000). Tijdschr Gerontol Geriatr. 31: 23–26.
Schwam EM, Abu-Shakra S, del Valle M, Townsend RJ, Carrillo MC, Fillit H. (2007). Alzheimers Dement. 3: 143–151.
Selai CE, Trimble MR. (2001). Neuropsychol Rehab. 11: 219–243.
Smith SC, Lamping DL, Banerjee S, Harwood R, Foley B, Smith P, Cook JC, Murray J, Prince M, Levin E, Mann A, Knapp M. (2005). Health Technol Assess. 9: 1–iv.
Sörensen S, Duberstein P, Gill D, Pinquart M. (2006). Lancet Neurol. 5: 961–973.
Sprangers MA, Schwartz CE. (1999). Soc Sci Med. 48: 1507–1515.
Terada S, Ishizu H, Fujisawa Y, Fujita D, Yokota O, Nakashima H, Haraguchi T, Ishihara T, Yamamoto S, Sasaki K, Nakashima Y, Kuroda S. (2002). Int J Geriatr Psychiatry. 17: 851–858.
The EuroQol Group. (1990). Health Policy. 16: 199–208.
The WHOQOL Group. (1998). Psychol Med. 28: 551–558.
Thomas P, Lalloue F, Preux PM, Hazif-Thomas C, Pariel S, Inscale R, Belmin J, Clement JP. (2006). Int J Geriatr Psychiatry. 21: 50–56.
Trial Designs and Outcomes in Dementia Therapeutic Research. (2006). London and New York: Taylor & Francis Group.
Trigg R, Jones RW, Skevington SM. (2007). Age Ageing. 36: 663–669.
Visser MR, Oort FJ, Sprangers MA. (2005). Qual Life Res. 14: 629–639.
Volicer L, Hurley AC, Camberg L. (1999). Journal of Mental Health and Aging. 5: 83–94.
Ware JE Jr., Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. (1995). Med Care. 33: AS264–AS279.
Ware JE Jr., Sherbourne CD. (1992). Med Care. 30: 473–483.
Wee HL, Machin D, Loke WC, Li SC, Cheung YB, Luo N, Feeny D, Fong KY, Thumboo J. (2007). Value Health. 10: 256–265.
Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS. (2000). J Am Med Dir Assoc. 1: 114–116.
Weisscher N, de Haan RJ, Vermeulen M. (2007). BMC Med Res Methodol. 7: 24.
Wolfs CA, Dirksen CD, Kessels A, Willems DC, Verhey FR, Severens JL. (2007). Health Qual Life Outcomes. 5: 33.
Zmud R, Armenakis AA. (1978). Acad Manage Rev. 3: 661–669.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Schölzel-Dorenbos, C.J.M., Krabbe, P.F.M., Olde Rikkert, M.G.M. (2010). Quality of Life in Dementia Patients and Their Proxies: A Narrative Review of the Concept and Measurement Scales. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_213
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_213
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine